PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 199 filers reported holding PDL BIOPHARMA INC in Q3 2016. The put-call ratio across all filers is 1.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $54,000 | +38.5% | 15,935 | 0.0% | 0.01% | +33.3% |
| Q2 2017 | $39,000 | +8.3% | 15,935 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $36,000 | +5.9% | 15,935 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $34,000 | -35.8% | 15,935 | 0.0% | 0.01% | -33.3% |
| Q3 2016 | $53,000 | +6.0% | 15,935 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $50,000 | -10.7% | 15,935 | 0.0% | 0.01% | -10.0% |
| Q1 2016 | $56,000 | 0.0% | 15,935 | 0.0% | 0.01% | 0.0% |
| Q4 2015 | $56,000 | -30.0% | 15,935 | 0.0% | 0.01% | -33.3% |
| Q3 2015 | $80,000 | -21.6% | 15,935 | 0.0% | 0.02% | -11.8% |
| Q2 2015 | $102,000 | -8.9% | 15,935 | 0.0% | 0.02% | -5.6% |
| Q1 2015 | $112,000 | – | 15,935 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 2,632,000 | $8,817,000 | 2.83% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 551,804 | $1,848,543,000 | 1.54% |
| Nine Chapters Capital Management LLC | 24,300 | $81,000 | 0.57% |
| GREAT POINT PARTNERS LLC | 645,000 | $2,161,000 | 0.55% |
| Virtus ETF Advisers LLC | 198,901 | $666,000 | 0.32% |
| GSA CAPITAL PARTNERS LLP | 1,521,224 | $5,096,000 | 0.27% |
| Amici Capital, LLC | 200,000 | $670,000 | 0.18% |
| Acrospire Investment Management LLC | 70,622 | $237,000 | 0.16% |
| RBF Capital, LLC | 273,976 | $918,000 | 0.16% |
| SECOR Capital Advisors, LP | 383,971 | $1,286,000 | 0.14% |